Koers Recipharm publ AB Swiss Exchange
Aandelen
SE0005757267
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- SEK | - |
2023 | Synokem Pharmaceuticals Limited verwierf 74% belang in Nitin Lifesciences Limited van Recipharm AB (publ). | CI |
2023 | Recipharm kondigt wijzigingen aan in CEO | CI |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01/01 |
Director of Finance/CFO | - | 03-04-23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01-03-21 |
Director/Board Member | 67 | 01-01-21 | |
Richard Ridinger
CHM | Chairman | 66 | 01-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,09% | 74,45 mld. | |
+11,05% | 9,18 mld. | |
+54,35% | 5,03 mld. | |
-12,85% | 5,02 mld. | |
+1,60% | 3,82 mld. | |
-20,85% | 2,41 mld. | |
+16,88% | 2,39 mld. | |
-29,25% | 2,27 mld. | |
+24,62% | 2,26 mld. |